The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Paul, Weiss, Rifkind, Wharton & Garrison LLP

1285 AVENUE OF THE AMERICAS, NEW YORK, NY 10019-6064, USA
Tel:
Work +1 212 373 3000
Fax:
Fax +1 212 757 3990
Web:
www.paulweiss.com
Beijing, Hong Kong, London, New York, Tokyo, Toronto and 2 more

Manuel S. Frey

Tel:
Work 212-373-3127
Email:
Paul, Weiss, Rifkind, Wharton & Garrison LLP

Work Department

Corporate, Finance

Position

ClickHereForAttorneyBio

Languages

French, German

Education

LL.M., Duke University School of Law, 1998; Second State Exam, Munich University School of Law, 2000; First State Exam, Munich University School of Law, 1997


United States: Finance

Structured finance: derivatives and structured products

Within: Structured finance: derivatives and structured products

Paul, Weiss, Rifkind, Wharton & Garrison LLP handles a variety of hedging and swap transactions for its substantial private equity and asset manager client base. The derivatives and structured products team has experience of handling standalone derivatives transactions, as well as advising on structured products in the context of M&A deals. Group head Manuel Frey advised Ariad Pharmaceuticals on the unwinding of outstanding convertible note hedge transactions in connection with its $5.2bn acquisition of Takeda Pharmaceutical Company. The team’s additional expertise encompasses OTC compliance, trading, and various other regulatory compliance matters.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to